Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Pediatric Brainstem and Recurrent Gliomas
NCT00021229Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- May 2001
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in brainstem glioma, malignant glioma, sponsored by National Cancer Institute. Started May 2001; status: terminated.
02
Drugs
03
Conditions
brainstem gliomamalignant glioma
Beyond the preview
Go deeper on NCT00021229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021229.